Exposure to antipsychotics (APs) during pregnancy is increasingly common. Most newer atypical drugs are less likely to affect fertility than the older typical APs. This unimpaired fecundity combined with deinstitutionalization of patients with psychiatric illness and more widespread off-label use of these drugs have resulted in a doubling in the use of APs during pregnancy in the last decade.
1,2